| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 49 | 0 | 2008 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 49 | 0 | 1997 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.100 | None | 1.000 | 47 | 0 | 2002 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 0.979 | 47 | 0 | 1990 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.957 | 46 | 0 | 2007 | 2019 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.978 | 46 | 0 | 1999 | 2019 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 45 | 0 | 1999 | 2020 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 45 | 0 | 1993 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.955 | 44 | 2 | 2003 | 2019 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 44 | 0 | 2002 | 2019 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 43 | 0 | 1995 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.100 | None | 0.976 | 42 | 1 | 1999 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.100 | None | 1.000 | 42 | 0 | 2000 | 2019 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.100 | None | 1.000 | 39 | 0 | 2009 | 2020 | |||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.100 | None | 0.974 | 38 | 0 | 1981 | 2019 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 37 | 1 | 1993 | 2020 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
phenotype | 0.100 | None | 0.973 | 37 | 0 | 2000 | 2019 | |||||||||
|
basigin (Ok blood group) | 0.458 | 0.769 | 2.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 37 | 0 | 2000 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.100 | None | 0.917 | 36 | 0 | 1998 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
phenotype | 0.100 | None | 0.886 | 35 | 0 | 1997 | 2019 | |||||||||
|
galectin 1 | 0.435 | 0.846 | 4.5E-03 |
|
phenotype | 0.100 | None | 0.971 | 35 | 0 | 1999 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 35 | 0 | 2005 | 2019 | ||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
phenotype | 0.100 | None | 0.971 | 34 | 0 | 2000 | 2019 | |||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.100 | None | 1.000 | 34 | 0 | 1998 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.100 | None | 0.941 | 34 | 0 | 1994 | 2019 |